{"schema_version":"secwatch.filing_event.v1","accession":"0001396814-23-000048","form_type":"8-K","ticker":"PCRX","cik":"0001396814","company_name":"Pacira BioSciences, Inc.","filed_at":"2023-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.783185+00:00","generated_at":"2026-06-10T08:38:09.608039+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pacira CEO David Stack to retire; board initiates search for successor","bullets":["Stack will remain as CEO until successor is appointed, then serve as consultant through August 2025.","Entitled to base salary through Sept 1, 2024; continues equity vesting and bonus eligibility for 2023-2024.","Board retains Klein Hersh International to lead comprehensive CEO search.","Transition agreement includes non-disparagement, cooperation, indemnification, and consulting fee of $20k/month for up to 15 hours.","Press release issued September 26, 2023; retirement effective upon appointment of new CEO."],"urls":{"canonical":"https://secwatch.observer/filing/0001396814-23-000048","json":"https://secwatch.observer/filing/0001396814-23-000048.json","markdown":"https://secwatch.observer/filing/0001396814-23-000048.md","text":"https://secwatch.observer/filing/0001396814-23-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1396814/000139681423000048/0001396814-23-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1396814/000139681423000048/pcrx-20230920.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T08:38:09.608039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"85e63b13f6","claim":"David Stack departed as Chief Executive Officer at Pacira BioSciences, Inc..","evidence_excerpt":"David Stack informed the Board of Directors (the \"Board\") of Pacira BioSciences, Inc. (the \"Company\") that he intends to retire as Chief Executive Officer of the Company and as a member of the Board effective immediately following the appointment of his successor as Chief Executive Officer in order to ensure a smooth transition of leadership.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681423000048/0001396814-23-000048-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}